As a first-time launcher, what does commercialization mean to you? The term’s definition is entirely variable depending upon who...
Read MoreThink your Biopharma startup is “too small” for cybersecurity risk? We see it all the time. Read these real cybersecurity breach...
Read MoreIn the first critical months a biopharmaceutical product is in-market, stakeholders need accessible, reliable information to make...
Read MoreWe’ve been discussing the importance of an emerging biopharma company’s supply chain team in our recent blog series, “Heroes in...
Read MoreWe’ve been discussing the importance of an emerging biopharma company’s supply chain team in our recent blog series, “Heroes in...
Read MoreWe recently discussed the importance of an emerging biopharma company’s supply chain team, and the reasons we consider them the...
Read MoreEmerging organizations and the leaders they hire naturally gravitate to what they know when it comes to choosing business...
Read MoreIn their February 2021 article “First-time launchers in the pharmaceutical industry”, McKinsey & Company reported that “many...
Read MoreGetting a first drug product approved is an exciting, promising milestone in an emerging biopharma company launching its first...
Read MoreSVA Life Sciences helps biopharmaceutical leaders navigate their successful commercialization journey – a common goal in our line...
Read More